IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long term replacement treatment

Panminerva Medica

Volumn 40, Issue 2, 1998, Pages 103-106

  Bona, G ^a,b   Rapa, A ^a   Boccardo, G ^b   Silvestro, L ^b   Chiorboli, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Hypothyroidism; Insulin like growth factor 1; Insulin like growth factor binding proteins 3

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CLINICAL TRIAL; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; METABOLISM; PRESCHOOL CHILD; TIME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; FEMALE; HUMANS; HYPOTHYROIDISM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; THYROXINE; TIME FACTORS;

EID: 0032086503     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, De Leon DD et al. Insulin-like growth factor-binding proteins. Rec Progr Horm Res 1991;46:99-163.
2. Blum WF, Ranke MB, Kietzmann K, Gauggel E. A specific radioimmunoassay for the GH-dependent somatomedin-binding proteins: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70: 1292-8.
3. Clemmons DR. Insulin-like growth factor binding proteins: roles in regulating IGF physiology. J Develop Physiol 1991;15:105-10.
4. Cohen P, Rosenfeld RG. Physiologic and clinical relevance of the Insulin-like growth factor binding proteins. Curr Opin Pediatr 1994;6: 462-7.
5. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone and IGF-binding proteins. J Clin Endocrinol Metab 1993;76:950-5.
6. Bona G, Aquili C, Ravanini P, Gallina MR, Cigolorti AC, Zaffaroni M, et al Growth hormone, insulin-like growth factor-1 and somatostatin in human fetus, newborn, mother plasma and amniotic fluid. Panminerva Med 1994;36:5-12.
7. Copeland KC, Franks RC. Plasma somatomedin-C concentration in congenital hypothyroidism. J Pediatr 1984;104:732-4.
8. Rodriguez-Arnao J, Miell J, Thomas M, McGregor AM, Ross RJ. Changes in hepatic insulin-like growth factor-binding proteins -1,-2 and -3 mRNA levels in rats with altered thyroid status. J Endocrinol 1994;140.251-5.
9. Nanto-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG. Mechanism of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. Endocrinology 1993;132:781-8.
10. Miell JR Zmi M, Quin JD, Jones J, Portioli I, Valcavi R. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with tolal thyroidectomy. J Clin Endocrinol Metab 1994;79:1507-12.
11. Mitchell ML, Helmos RJ, Moses AC. Somatomedin-C/insulin-like growth factor-1 in infants with congenital hypothyroidism during the first week of life. Clin Endocrinol 1987;27:625-8.
12. Mitchell ML, Helmos RJ, Feingold M, Moses AC. The relationship of insulin-like growth factor-1 to total thyroxine in normal and low birth weight infants. Pediatr Res 1989;25:336-8.
13. Valcavi R, Zini M, Portioli I. Thyroid hormones and growth hormone secretion. J Endocrinol Invest 1992;15:313-30.
14. Chemausek SD, Underwood LE, Utiger RD, Van Wyk JJ. Growth hormone secretion and plasma somatomedin C in primary hypothyroidism. Oxford: Clin Endocrinol 1983;19:337-44.
15. Chernausek SD, Underwood LE, Van Wyk JJ. Influence of hypothyroidism on growth hormone binding by rat liver. Endocrinology 1982;111.1534-8.
16. Leger J, Czernichow P. Low IGF-1 serum levels in children with congenital hypothyroidism and normal value during LT4 therapy. Horm Res 1989;31(S1):76.
17. Bona G, Campra D, Altare I, Paniccia P, Costa L, Zaffaroni M. Studio dei livelli plasmatici di IGF-1 in soggetti affetti da ipotiroidismo congenito in trattamento sostitutivo. Am del Congresso Nazionale della SIEDP 1991:51-2.
18. Radetti G, Castellan L, Tatò L, Platter K, Gentili L, Adami S. Bone mineral density in children and adolescent sample treated with high doses of L-tyroxine. Horm Res 1994;39:127.
19. Tatò L, Antoniazzi F, Valentini R, Tagliaro F, Gambaro G, Costantini E et al. GH Binding Protein behaviour by size exclusion HPLC in congenital hypothyroidism. Horm Res 1994;41:136.
20. Tatò L, Antoniazzi F, Spolettini E, Tarducci E. IGF-1 and IFG-1 binding proteins in the first months of congenital hypothyroidism treatment. Horm Res 1989;31:S1.